Related Experiment Videos

Quantitative ultrastructure of the myocardium in chronic aortic valve disease

Insights

In advanced mixed aortic valve disease, a reduced intracellular contractile material and increased sarcoplasmic volume lead to impaired left ventricular contractility. This cellular change explains reduced ejection fraction in these patients.

Area of Science:

  • Cardiovascular Pathology
  • Cardiac Hypertrophy
  • Aortic Valve Disease

Background:

  • Chronic aortic valve disease leads to significant left ventricular remodeling.
  • Understanding cellular changes in hypertrophy is crucial for managing heart failure.

Purpose of the Study:

  • To investigate the morphometric and hemodynamic differences in the left ventricle among patients with distinct chronic aortic valve diseases.
  • To identify cellular mechanisms underlying impaired contractility in mixed aortic valve disease.

Main Methods:

  • Light and electron microscopic morphometry of left ventricular free wall tissue samples.
  • Hemodynamic assessment, including ejection fraction and wall stress, before open-heart surgery.
  • Comparison of intracellular contractile material, sarcoplasmic volume, mitochondrial volume, and interstitial fibrosis across patient groups.

Main Results:

  • Patients with mixed aortic valve disease exhibited higher left ventricular mass and lower ejection fraction compared to aortic stenosis.
  • Intracellular contractile material was reduced, and sarcoplasmic volume was increased in mixed aortic valve disease versus aortic stenosis.
  • No significant differences in mitochondrial volume or interstitial fibrosis were observed between groups.

Conclusions:

  • An intracellular deficiency of myofibrils contributes to impaired contractility in advanced hypertrophy associated with mixed aortic valve disease.
  • This cellular deficit is a key factor in the reduced ejection fraction seen in these patients.

Related Concept Videos